Durvalumab as a maintenance therapy after a definitive chemoradiotherapy for a stage III non-small cell lung cancer - an interim analysis of the PACIFIC trial

被引：0
|
作者：
Kawecki, Maciej [1 ]
机构：
[1] Maria Sklodowska Curie Inst Oncol, Dept Radiotherapy & Oncol, Warsaw, Poland
来源：
ONCOLOGY IN CLINICAL PRACTICE | 2018年 / 14卷 / 03期
关键词：
D O I：
10.5603/OCP.2018.0023
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：167 / 170
页数：4
相关论文
共 50 条
  • [21] Neoadjuvant Chemoradiotherapy for Stage iii Non-Small Cell Lung Cancer
    Sher, David J.
    FRONTIERS IN ONCOLOGY, 2017, 7
  • [22] Patterns and Incidence of Pneumonitis and Initial Treatment Outcomes with Durvalumab Consolidation Therapy after Radical Chemoradiotherapy for Stage III Non-Small Cell Lung Cancer
    Sato, Mizuki
    Odagiri, Kazumasa
    Tabuchi, Yuya
    Okamoto, Hiroaki
    Shimokawa, Tsuneo
    Nakamura, Yukiko
    Hata, Masaharu
    CANCERS, 2024, 16 (06)
  • [23] Is durvalumab the solution for unresectable stage III non-small cell lung cancer?
    Duma, Narjust
    Mansfield, Aaron S.
    TRANSLATIONAL CANCER RESEARCH, 2018, 7 : S89 - S93
  • [24] Implementation of durvalumab maintenance treatment after concurrent chemoradiotherapy in inoperable stage III non-small cell lung cancer (NSCLC)-a German radiation oncology survey
    Kaesmann, Lukas
    Eze, Chukwuka
    Taugner, Julian
    Roengvoraphoj, Olarn
    Belka, Claus
    Manapov, Farkhad
    TRANSLATIONAL LUNG CANCER RESEARCH, 2020, 9 (02) : 288 - 293
  • [25] Aumolertinib Maintenance after Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer: Interim Results of the Phase III Study (POLESTAR)
    Yu, J.
    Meng, X.
    Ge, H.
    Liu, Q.
    Ning, F.
    Cheng, Y.
    Wang, J.
    Zhang, X.
    Wu, G.
    Chen, J.
    Xu, Y.
    Zhao, X.
    Lu, K.
    Jiang, O.
    Lv, D.
    Xie, C.
    Li, X.
    Yao, Y.
    Dong, X.
    Liu, B.
    Fang, J.
    Yang, K.
    Zhu, B.
    Lin, Q.
    Shi, J.
    Ye, S.
    Shi, A.
    Cang, S.
    Li, J.
    Xu, B.
    Li, H.
    Zhang, Z.
    Yin, J.
    Wang, G.
    Liu, C.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S6 - S7
  • [26] Salvage Surgery After Definitive Chemoradiotherapy for Non-small Cell Lung Cancer
    Casiraghi, Monica
    Maisonneuve, Patrick
    Piperno, Gaia
    Bellini, Roberto
    Brambilla, Daniela
    Petrella, Francesco
    De Marinis, Filippo
    Spaggiari, Lorenzo
    SEMINARS IN THORACIC AND CARDIOVASCULAR SURGERY, 2017, 29 (02) : 233 - 241
  • [27] Salvage Surgery After Definitive Chemoradiotherapy for Non-Small Cell Lung Cancer
    Lampridis, Savvas
    ANNALS OF THORACIC SURGERY, 2021, 112 (06): : 2108 - 2108
  • [28] Radiation pneumonitis after definitive chemoradiation and durvalumab for non-small cell lung cancer
    Voong, Khinh Ranh
    Naidoo, Jarushka
    LUNG CANCER, 2020, 150 : 249 - 251
  • [29] Durvalumab after concurrent chemoradiotherapy in inoperable stage III non-small cell lung cancer (NSCLC) - a German radiation oncology survey
    Kaesmann, Lukas
    Eze, Chukwuka
    Taugner, Julian
    Roengvoraphoj, Olarn
    Belka, Claus
    Manapov, Farkhad
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [30] Treatment Outcome and Safety of Durvalumab After Concurrent Chemoradiotherapy in Elderly Patients With Unresectable Stage III Non-Small Cell Lung Cancer
    Kim, S.
    Kim, N.
    Chung, S.
    Choi, J.
    Hyun, I.
    Yeo, Y.
    Park, J.
    Jang, S.
    Kim, T.
    Sim, Y.
    Lee, C.
    Kim, J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
12345